Ocrelizumab Trial Fills Research Gap for Black, Hispanic MS Patients

(MedPage Today) -- DENVER -- Among Black/African American and Hispanic/Latino patients with relapsing multiple sclerosis (MS) in the phase IV CHIMES trial, half achieved a combined measure for no evidence of disease activity (NEDA) with ocrelizumab...
Source: MedPage Today Public Health - Category: American Health Source Type: news